ClinicalTrials.Veeva

Menu

Almond Milk With Vitamin D: Impact on Vitamin D Status

University of Florida logo

University of Florida

Status

Completed

Conditions

Kidney Failure, Chronic
Renal Insufficiency, Chronic

Treatments

Dietary Supplement: NanoD4CKD
Dietary Supplement: MicroD4CKD

Study type

Interventional

Funder types

Other

Identifiers

NCT05165173
OCR41655 (Other Identifier)
IRB202102986

Details and patient eligibility

About

The overall goal is to enhance vitamin D status in a safe and effective manner. A 3-week randomized comparator-controlled trial among a cohort of adults with CKD (stages 3-5) (n=24) will test the main objective: Evaluate the bioefficacy of D3 in micro- and nanoparticles (4000IUs) in almond milk with the sub-objective of: Explore the effect of D3 in micro- and nanoparticles (4000IUs) in almond milk on inflammation markers CRP, TNF-α and IL-6.

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults who have been diagnosed with CKD
  • have no GI disorders or GI disturbances
  • age 18 years or older
  • no food allergies or dietary restrictions
  • all with no contraindications to consuming anything by mouth as per their physician

Exclusion criteria

  • no diagnosis of CKD
  • GI disorders
  • gastrointestinal disturbances
  • under 18 years old
  • food allergies to almonds
  • Dietary restrictions as medically indicated
  • trouble chewing/swallowing as confirmed by physician

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

21 participants in 2 patient groups

Intervention
Experimental group
Description:
Based on estimated glomerular filtration rate (eGFR) and vitamin D levels, participants will be placed into the nanoparticle group.
Treatment:
Dietary Supplement: NanoD4CKD
Comparator
Active Comparator group
Description:
Based on the estimated glomerular filtration rate (eGFR) and vitamin D levels, participants will be placed into the microparticle group.
Treatment:
Dietary Supplement: MicroD4CKD

Trial contacts and locations

1

Loading...

Central trial contact

Jeanette M Andrade, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems